Reliance Industries (RIL) accounted for the chunk of Unit Trust of India's (UTI) equity portfolio as on September 2001. The data available for 66 schemes reveals that RIL accounted for 18.59 per cent (Rs 2,655.45 crore) of the total equity investment. It was followed by ITC at 11.40 per cent (Rs 1,629.38 crore).
Hindustan Lever ranked third shared 10.93 per cent (Rs 1,561.77 crore) followed by Infosys Technologies at fifth with 6.46 per cent (Rs 922.87 crore).
Reliance Petroleum ranked third in US-64 portfolio alone and fifth in the aggregate of 66 schemes, accounted for 5.67 per cent (Rs 809.60 crore).
Interestingly, the fund house reduced its exposure in fifteen of the top twenty holdings from June 2001 to September 2001. UTI's top 20 equity holdings of 66 schemes with equity investment accounted for more than 82 per cent of its equity holding in June 2001. The share slipped to 80 per cent in September 2001. This is despite to the fact that its equity investment portfolio has been spread out in more than 400 scrips.
The fund house has reduced its exposure in Reliance Industries, that still continues to be top its portfolio chart. The fund house sold 28.7 lakh shares of RIL accounting for 2.8 per cent of its holding, during the period. However, this augurs well for the fund house as the counter slipped by 28 per cent during the period. Similarly, it reduced its exposure in Infosys Technologies selling 3.19 lakh shares. Infosys had also dipped over 37 per cent between June 2001 to September 2001.
The fund also offloaded heavily on Hindustan Lever and Reliance Petroleum counter during the period.
Meanwhile, UTI has increased it stake in Hindalco by 2.50 lakh shares. It also increased its stake in Larsen and Toubro by 5.20 lakh shares, Bharat Petroleum Corporation (5.70 lakh shares) , Ranbaxy Laboratories (6.92 lakh shares) and National Aluminium (4.12 lakh shares) during the period. Of these Ranbaxy Laboratories counter had gained more than 35 per cent during the period.
